Alyeska Investment Group, L.p.

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
492
Total Value
25057785470
Accession Number
0001172661-25-002312
Form Type
13F-HR
CIK
0001453072
Manager Name
Alyeska Investment Group, L.p.
Data Enrichment
96% identified
470 identified22 unidentified

Holdings

492 positions
Manager:
SEC
Search and click to pin securities to the top
Page 22 of 25
KB HOME
KBH|48666K109
Shares:
29135
Value:
$1.7B
Regulus Therapeutics Inc.
RGLS|75915K309
Shares:
937500(-9.6%)
Value:
$1.6B(+0.1%)
Health Catalyst, Inc.
HCAT|42225T107
Shares:
349194(-82.7%)
Value:
$1.6B(-88.9%)
ACELYRIN, Inc.
SLRN|00445A100
Shares:
615878(-59.4%)
Value:
$1.5B(-68.0%)
Applied Therapeutics, Inc.
APLT|03828A101
Shares:
3107497(+14.8%)
Value:
$1.5B(-34.5%)
P3 Health Partners Inc.
PIII|744413105
Shares:
9045340(-24.0%)
Value:
$1.5B(-44.6%)
Ceribell, Inc.
CBLL|15678C102
Shares:
75000(-40.0%)
Value:
$1.4B(-55.5%)
578784100
578784100
Shares:
125000
Value:
$1.4B
NOVARTIS AG
NVS|66987V109
Shares:
11722
Value:
$1.3B
LINCOLN ELECTRIC HOLDINGS INC
LECO|533900106
Shares:
6340
Value:
$1.2B
ACHIEVE LIFE SCIENCES, INC.
ACHV|004468500
Shares:
421000(+0.0%)
Value:
$1.1B(-24.1%)
Forge Global Holdings, Inc.
FRGE|34629L103
Shares:
1990391
Value:
$1.1B
PERMA FIX ENVIRONMENTAL SERVICES INC
PESI|714157203
Shares:
147417(-78.9%)
Value:
$1.1B(-86.2%)
Lineage, Inc.
LINE|53566V106
Shares:
17697(-98.5%)
Value:
$1.0B(-98.5%)
Acumen Pharmaceuticals, Inc.
ABOS|00509G209
Shares:
939603(+0.0%)
Value:
$1.0B(-36.0%)
Context Therapeutics Inc.
CNTX|21077P108
Shares:
1663355(+0.0%)
Value:
$1.0B(-41.7%)
Unicycive Therapeutics, Inc.
UNCY|90466Y103
Shares:
1750000(+0.0%)
Value:
$1.0B(-27.6%)
FLUOR CORP
FLR|343412102
Shares:
28017(-98.6%)
Value:
$1.0B(-99.0%)
UR-ENERGY INC
URG|91688R108
Shares:
1454894(-77.8%)
Value:
$980.7M(-87.0%)
Qorvo, Inc.
QRVO|74736K101
Shares:
12936(+4.3%)
Value:
$936.7M(+8.0%)